LOGO
pl en

The role of neoadjuvant chemotherapy in the management of advanced ovarian cancer in geriatric patients

Ewelina Kojs-Pasińska1, Bożena Cybulska-Stopa1,2, Krzysztof Koper3,4, Konrad Dziobek4, Marek Dziechciowski4, Agnieszka Chamier-Ciemińska4, Joanna Streb1,2, Piotr J. Wysocki1,2, Łukasz Wicherek4

Affiliacja i adres do korespondencji
Curr Gynecol Oncol 2016, 14 (4), p. 212–221
DOI: 10.15557/CGO.2016.0026
Streszczenie

It is increasingly common for ovarian cancer to affect older women, with over half of all cases involving patients aged 65 years and older. Unfortunately, elderly patients with ovarian malignancy tend to be treated less aggressively than younger patients, with less extensive surgery and less intensive chemotherapy regimens. This is due to a variety of factors, such as overall medical fitness and the function of specific organs. Moreover, multiple morbidities are typical for geriatric patients and affect their eligibility for certain forms of cancer therapy as well as their treatment outcomes, which are commonly less satisfactory than in younger patients. Additionally, for fear of complications, treating physicians sometimes limit the extent of the necessary surgery, or adjust chemotherapy doses, even though such a course of management tends to be largely misguided. One available management option is neoadjuvant chemotherapy followed by a surgical treatment known as interval debulking surgery. This type of combination therapy is associated with fewer postoperative complications, thus increasing the patient’s chances of receiving a full course of adjuvant treatment. The decision to begin treatment with neoadjuvant chemotherapy tends to restrict later surgical therapy; however, under certain circumstances, this therapy can be a valid therapeutic option and, in fact, facilitate surgery. Prior to initiating therapy in elderly patients, their eligibility for combination therapy must be evaluated and the geriatric assessment of their performance and condition must be considered during the course of interdisciplinary preoperative management.

Słowa kluczowe
ovarian cancer, neoadjuvant chemotherapy, primary cytoreductive surgery, geriatric patients, geriatric oncology